About 1 in 8 women will be diagnosed with breast cancer in her lifetime. But the proportion who develop the common cancer as a result of a genetic mutation — namely to the BRCA1 or BRCA2 genes — is ...

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

ROANOKE, Va. – It’s estimated that more than 42,000 people will die from breast cancer this year, according to the American Cancer Society. To help you understand if you’re at a greater risk of ...

More and more studies show that men face risks of cancer from BRCA1 and BRCA2 genetic mutations that are most often associated with breast and ovarian cancers in women. According to a July 25 JAMA ...

HealthDay News — Only about one-third of women receive genetic counseling before they undergo testing for BRCA mutations, and patients who receive genetic counseling beforehand display better ...

Perhaps the best known of all the cancer predisposition genes are inherited mutations in the genes BRCA1 and BRCA2. They were originally associated with an increased risk of breast and ovarian cancers ...

The BRCA 14 nano-chip test, which is common in Israel, targets women of Ashkenazi and Ethiopian descent who have not been ...

In the advent of targeted therapy in ovarian cancer, BRCA gene & “BRCA-ness” genes play a pivotal role in identifying the right patient for the right treatment. In this talk, we will details on the ...

Siddhartha Yadav, MD, discusses real-world data demonstrating the mass underutilization of BRCA testing in patients with breast cancer. At San Antonio Breast Cancer Symposium 2023, Siddhartha Yadav, ...

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.

Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.